Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,942,208
-$5,824,517 QoQ
Shares Held
137,584
-17.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#545
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $248,035,659 across 15 Drug Manufacturers - General names. JNJ ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
346,193 | $44,485,800 | |
| 2 | AMGN |
Amgen Inc
|
97,240 | $35,212,548 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
137,584 | $34,942,208 | |
| 4 | LLY |
ELI LILLY & Co
|
22,773 | $27,314,621 | |
| 5 | ABBV |
AbbVie Inc.
|
87,496 | $22,017,493 | |
| 6 | PFE |
Pfizer Inc
|
873,428 | $21,032,146 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
302,317 | $17,419,505 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,450 | $16,102,033 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,942,208 | 137,584 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $40,766,725 | 166,776 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,226,993 | 179,884 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $34,599,186 | 186,599 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $28,758,395 | 188,271 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,713,085 | 191,227 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $24,624,013 | 170,267 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $24,513,195 | 151,260 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $21,148,475 | 144,694 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $19,378,275 | 122,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,709,109 | 100,224 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,670,729 | 81,353 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,789,636 | 83,311 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,056,770 | 71,334 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,623,970 | 82,785 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,629,304 | 95,674 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $18,746,121 | 105,606 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $21,955,429 | 123,881 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $23,812,601 | 139,198 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $24,906,045 | 154,217 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $33,034,653 | 200,526 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $37,938,389 | 230,839 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $38,675,033 | 245,743 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $38,241,316 | 256,860 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $34,587,245 | 245,945 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $31,547,911 | 240,585 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||